-
Is your family planning facility seeing more women who are HIV-positive? Statistics point to a yes. In 2003, women accounted for 27% of the estimated 32,048 diagnoses of HIV infection in the United States, according to statistics from the Atlanta-based Divisions of HIV/AIDS Prevention of the Centers for Disease Control and Prevention (CDC).
-
How do you broaden access to family planning services? Some family planning agencies are looking to touchscreen technology to get information front and center to those who may need their services.
-
The young woman in your examination room has questions about how emergency contraception pills (ECPs) works. How do you explain the methods mechanism of action?
-
The need for female-controlled protection against HIV and sexually transmitted diseases (STDs) has never been greater. While early in the epidemic, HIV infection and AIDS were diagnosed for relatively few women, the HIV/AIDS epidemic now represents a growing and persistent health threat to women in the United States as well as throughout the world.
-
Keegan L. CAM and fibromyalgia. Altern Ther Women's Health 2005;7(6):41-45.
-
Judge removes ban on sale of ephedra. Altern Ther Women's Health 2005;7(6):48.
-
Majority of older adults use CAM. Altern Ther Women's Health 2005;7(6):48.
-
Berga SL. Long-term effects of vitamin E on cardiovascular disease and cancer. Altern Ther Women's Health 2005;7(6):45-47.
-
As a way to indirectly investigate the effects of lubricating products used by infertile women during intercourse on sperm quality, semen from 22 normospermic men was tested against several common lubricants (Pre-Seed®, Astroglide®, K-Y® Sensitive®, K-Y® Warming®, and K-Y® Tingling) and natural oils (baby, canola, sesame, and mustard) at 0, 5, 30 and 60 minutes.
-
Bevacizumab is a humanized monoclonal antibody targeting vascular endothelial growth factor and has documented single-agent activity in patients with recurrent ovarian cancer.